Literature DB >> 21871277

Creation of a quantitative recipient risk index for mortality prediction after cardiac transplantation (IMPACT).

Eric S Weiss1, Jeremiah G Allen, George J Arnaoutakis, Timothy J George, Stuart D Russell, Ashish S Shah, John V Conte.   

Abstract

BACKGROUND: No recipient risk index exists predicting short-term mortality after orthotopic heart transplantation (OHT). We utilized United Network for Organ Sharing (UNOS) data to develop a novel quantitative recipient risk score for use in OHT.
METHODS: A prospectively collected open cohort of 21,378 primary OHT patients (1997 to 2008) was randomly divided into subgroups. The training cohort (n=17,079) was used for score derivation and the test cohort (n=4,299) was used for independent validation. Recipient specific variables associated with 1-year mortality (exploratory p value<0.2) were incorporated stepwise into a multivariable logistic regression model. The final model contained variables which maximized explanatory power (assessed by pseudo R2, area under the curve, and likelihood-ratio test). A risk index was created by apportioning points approximating the relative impact of variables on 1-year mortality. The Kaplan-Meier method was used to assess impact of risk score on short-term survival.
RESULTS: The 50-point scoring system incorporated 12 recipient specific variables. Derivation and validation cohort scores ranged from 0 to 33 and 0 to 27, respectively (mean 6.1±3.7 and 6.1±3.7). Each point increased the odds of 1-year death by 14% in the derivation cohort (odds ratio 1.14 [1.13 to 1.15], p<0.001) and 15% in the validation cohort (odds ratio 1.15 [1.12 to 1.17], p<0001). One-year survivals in the validation cohort (by increments of 3 points) were the following: 0 to 2 (92.5%); 3 to 5 (89.9%); 7 to 9 (86.3%); and 10 or greater (74.9%); p<0.001. Patients transplanted with risk scores of 20 or higher had 1-year mortality rates greater than 50%.
CONCLUSIONS: We present a novel internally validated OHT recipient risk score, which is highly predictive of 1-year mortality. This risk index may prove valuable for patient prognosis, organ allocation, and research stratification in OHT.
Copyright © 2011 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21871277     DOI: 10.1016/j.athoracsur.2011.04.030

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  38 in total

1.  Effect of sensitization in US heart transplant recipients bridged with a ventricular assist device: update in a modern cohort.

Authors:  George J Arnaoutakis; Timothy J George; Arman Kilic; Eric S Weiss; Stuart D Russell; John V Conte; Ashish S Shah
Journal:  J Thorac Cardiovasc Surg       Date:  2011-08-11       Impact factor: 5.209

2.  Considerations for patients awaiting heart transplantation-Insights from the UK experience.

Authors:  Guy A MacGowan; David S Crossland; Asif Hasan; Stephan Schueler
Journal:  J Thorac Dis       Date:  2015-03       Impact factor: 2.895

3.  Risk factors for early death in patients bridged to transplant with continuous-flow left ventricular assist devices.

Authors:  George J Arnaoutakis; Timothy J George; Arman Kilic; Claude A Beaty; Eric S Weiss; John V Conte; Ashish S Shah
Journal:  Ann Thorac Surg       Date:  2012-03-17       Impact factor: 4.330

4.  Contemporary etiologies, risk factors, and outcomes after pericardiectomy.

Authors:  Timothy J George; George J Arnaoutakis; Claude A Beaty; Arman Kilic; William A Baumgartner; John V Conte
Journal:  Ann Thorac Surg       Date:  2012-05-22       Impact factor: 4.330

5.  How to obtain and maintain favorable results after heart transplantation: keys to success?

Authors:  Johan J A Van Cleemput; Tom O M Verbelen; Lucas N L Van Aelst; Filip R L Rega
Journal:  Ann Cardiothorac Surg       Date:  2018-01

Review 6.  Donor selection in heart transplantation.

Authors:  Ahmet Kilic; Sitaramesh Emani; Chittoor B Sai-Sudhakar; Robert S D Higgins; Bryan A Whitson
Journal:  J Thorac Dis       Date:  2014-08       Impact factor: 2.895

7.  Cardiac transplantation can be safely performed using selected diabetic donors.

Authors:  Sharven Taghavi; Senthil N Jayarajan; Lynn M Wilson; Eugene Komaroff; Jeffrey M Testani; Abeel A Mangi
Journal:  J Thorac Cardiovasc Surg       Date:  2013-03-13       Impact factor: 5.209

8.  Comparison of early versus delayed timing of left ventricular assist device implantation as a bridge-to-transplantation: An analysis of the UNOS dataset.

Authors:  Shuichi Kitada; P Christian Schulze; Zhezhen Jin; Kevin Clerkin; Shunichi Homma; Donna M Mancini
Journal:  Int J Cardiol       Date:  2015-11-09       Impact factor: 4.164

9.  Preoperative assessment of high-risk candidates to predict survival after heart transplantation.

Authors:  P Christian Schulze; Jeffrey Jiang; Jonathan Yang; Faisal H Cheema; Kenneth Schaeffle; Tomoko S Kato; Maryjane Farr; Susan Restaino; Mario Deng; Mathew Maurer; Evelyn Horn; Farhana Latif; Paolo C Colombo; Ulrich Jorde; Nir Uriel; Jennifer Haythe; Rachel Bijou; Ron Drusin; Sun Hi Lee; Hiroo Takayama; Yoshifumi Naka; Donna M Mancini
Journal:  Circ Heart Fail       Date:  2013-03-15       Impact factor: 8.790

10.  Septuagenarians bridged to heart transplantation with a ventricular assist device have outcomes similar to younger patients.

Authors:  Timothy J George; Arman Kilic; Claude A Beaty; John V Conte; Kaushik Mandal; Ashish S Shah
Journal:  Ann Thorac Surg       Date:  2013-02-22       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.